Free. Unsubscribe any time.
BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. filed 56 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 210 transactions and 3,353,627 shares. 20 carry the SEC's AFF10B5ONE flag; 36 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-20, came 17 days after the one before it (2026-08-03) and reports 7 transactions against 1 in the filing before it.
- The sales it reports total 44,980 shares, 42,980 more than the 2,000 in the filing before it.
- Its 56 plan statements rank 88th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 56 filings on file run from 2025-01-30 to 2026-08-20, and state 12 plan adoption dates, from 2024-03-22 to 2026-05-13.
Trades in BridgeBio Pharma, Inc. 210
- Kumar Neil — 2025-01-28 · S · 326,932 shares
- STEPHENSON BRIAN C — 2025-01-28 · S · 68,000 shares
- Kumar Neil — 2025-01-29 · S · 269,068 shares
- Kumar Neil — 2025-01-29 · S · 4,000 shares
- Kumar Neil — 2025-02-19 · S · 31,467 shares
- Kumar Neil — 2025-02-19 · S · 76 shares
- STEPHENSON BRIAN C — 2025-02-19 · S · 4,148 shares
- Kumar Neil — 2025-02-25 · S · 37,899 shares
- Kumar Neil — 2025-02-25 · S · 37,101 shares
- STEPHENSON BRIAN C — 2025-02-25 · S · 8,400 shares
- STEPHENSON BRIAN C — 2025-02-25 · S · 100 shares
- Valantine Hannah — 2025-03-06 · S · 12,875 shares
Adoption dates in BridgeBio Pharma, Inc. 12
- 2024-03-22 — stated in 10 filings
- 2024-08-28 — stated in 3 filings
- 2024-12-05 — stated in 2 filings
- 2024-12-30 — stated in 3 filings
- 2025-03-31 — stated in 20 filings
- 2025-05-08 — stated in 1 filing
- 2025-06-27 — stated in 3 filings
- 2025-09-08 — stated in 5 filings
- 2025-11-14 — stated in 3 filings
- 2025-12-03 — stated in 2 filings
- 2026-03-16 — stated in 3 filings
- 2026-05-13 — stated in 1 filing
Results prints in BridgeBio Pharma, Inc. 9
- 2025-01-13
- 2025-02-20
- 2025-04-29
- 2025-08-05
- 2025-10-29
- 2026-01-12
- 2026-02-24
- 2026-05-07
- 2026-08-10
Trades before a print in BridgeBio Pharma, Inc. 33
- 0 days before the 2025-08-05 print — 2025-08-05 · S · Ellis Andrea · 17,167 shares
- 0 days before the 2025-10-29 print — 2025-10-29 · S · MCCORMICK FRANK · 111,755 shares
- 0 days before the 2025-10-29 print — 2025-10-29 · S · MCCORMICK FRANK · 31,116 shares
- 0 days before the 2025-10-29 print — 2025-10-29 · S · MCCORMICK FRANK · 3,497 shares
- 0 days before the 2025-10-29 print — 2025-10-29 · S · MCCORMICK FRANK · 8,598 shares
- 0 days before the 2025-10-29 print — 2025-10-29 · S · MCCORMICK FRANK · 43,393 shares
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Kumar Neil · 11,217 shares
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Kumar Neil · 8,333 shares
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Kumar Neil · 450 shares
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Kumar Neil · 11,217 shares
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Kumar Neil · 8,334 shares
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Kumar Neil · 449 shares
Interval to BridgeBio Pharma, Inc.’s next reported results date
How the interval and sources are counted →
- 33within 5 days
- 41within 10 days
- 0shortest, days
- 7no later print
- Kumar Neil 2025-02-19 · S · 1 day before the 2025-02-20 print · Chief Executive Officer
- Kumar Neil 2025-02-19 · S · 1 day before the 2025-02-20 print · Chief Executive Officer
- STEPHENSON BRIAN C 2025-02-19 · S · 1 day before the 2025-02-20 print · Secretary, Treasurer & CFO
- Kumar Neil 2025-04-22 · S · 7 days before the 2025-04-29 print · Chief Executive Officer
- Ellis Andrea 2025-08-05 · S · 0 days before the 2025-08-05 print
- MCCORMICK FRANK 2025-10-27 · S · 2 days before the 2025-10-29 print
- MCCORMICK FRANK 2025-10-29 · S · 0 days before the 2025-10-29 print
- MCCORMICK FRANK 2025-10-29 · S · 0 days before the 2025-10-29 print
- MCCORMICK FRANK 2025-10-29 · S · 0 days before the 2025-10-29 print
- MCCORMICK FRANK 2025-10-29 · S · 0 days before the 2025-10-29 print
- MCCORMICK FRANK 2025-10-29 · S · 0 days before the 2025-10-29 print
- Kumar Neil 2026-01-08 · S · 4 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-08 · S · 4 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-08 · S · 4 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-08 · S · 4 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-08 · S · 4 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-08 · S · 4 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-09 · S · 3 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-09 · S · 3 days before the 2026-01-12 print · Chief Executive Officer
- Kumar Neil 2026-01-09 · S · 3 days before the 2026-01-12 print · Chief Executive Officer
Adoption dates BridgeBio Pharma, Inc. states
- 2024-03-22 in 10 filings
- 2024-08-28 in 3 filings
- 2024-12-05 in 2 filings
- 2024-12-30 in 3 filings
- 2025-03-31 in 20 filings
- 2025-05-08 in 1 filing
- 2025-06-27 in 3 filings
- 2025-09-08 in 5 filings
- 2025-11-14 in 3 filings
- 2025-12-03 in 2 filings
- 2026-03-16 in 3 filings
- 2026-05-13 in 1 filing
Filing text: “10b5-1 sales plan adopted by the Reporting Person on March 22, 2024”
Reported results dates on file
- 2025-01-13
- 2025-02-20
- 2025-04-29
- 2025-08-05
- 2025-10-29
- 2026-01-12
- 2026-02-24
- 2026-05-07
- 2026-08-10
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.